MRTNZ

MRTNZ Investment Office · S&P 500 · The 360 Vantage

MO · NYSE

Altria Group, Inc.

Health Care · Medicinal Chemicals and Botanical Products

Reference price$69.10As of Jul 30, 2026
Market capitalization$115B
52-week range$54.70–$77.06
S&P 500 portfolio weight0.20%
Data qualitycomplete

Street view

Analyst targets

Published sell-side aggregation—not an MRTNZ forecast.

Low$59.00-14.6% vs. reference
Average$70.38+1.9% vs. reference
High$79.00+14.3% vs. reference
4 Buy6 Hold1 Sell

Forward calendar

Current earnings expectations

Consensus may change until the company reports.

Expected reportNot availableJun 2026
Consensus EPS$1.504 estimates
Expected range$1.48–$1.52Low to high EPS
Dec 2026$5.70Street EPS consensus
Dec 2027$5.87Street EPS consensus
Dec 2028$6.06Street EPS consensus

Reported results

Annual financial snapshot

Fiscal period ended Dec 31, 2025.

MetricCurrentPrior
Revenue-3.1% YoY$23.28B$24.02B
Operating income$9.9B$11.24B
Net income$6.95B$11.26B
Operating cash flow$9.29B$8.75B
Capital expenditures($0.22B)($0.14B)

Current context

Related news

Company-linked articles surfaced by Nasdaq.

RTTNews

Altria Group Inc. Reports Drop In Q2 Profit

BNK Invest

See Which Recent 13F Filers Hold MO

NASDAQ.com

Pre-Market Earnings Report for July 30, 2026 : MA, BMY, MO, SNY, SO, TT, KKR, VLO, PWR, ICE, EPD, CI

Evidence

Sources & method

Nasdaq quote →Nasdaq summary →Earnings forecast →Annual financials →Official S&P 500-tracking holdings →

Facts, estimates, and scenarios are kept separate. Analyst targets and EPS expectations are third-party estimates, not MRTNZ forecasts. Index weight uses the official IVV portfolio as the denominator. Illustrative research, not investment advice.